Dendritic NanoTechnologies' Founder to Present Today at FDA Center for Drug Evaluation and Research

Dr. Tomalia Helps FDA Scientists Better Understand Nanotechnology and Prepare

for Forthcoming FDA Review of Nanotechnology-Based Therapies



Mar 24, 2005, 00:00 ET from Nanotechnology: Its Impact on Biology, Pharma Delivery, MRI Imaging and

    MOUNT PLEASANT, Mich., March 24 /PRNewswire/ -- Dr. Donald Tomalia, the
 founder of Dendritic NanoTechnologies Inc. (DNT), is presenting today at a
 two-day workshop being held by the Federal Drug Administration. Dr. Tomalia
 will kick off today's workshop with a presentation titled:  "Dendrimer-Based
 Nanotechnology: Its Impact on Biology, Pharma Delivery, MRI Imaging and